🇺🇸 FDA
Patent

US 10494632

Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof

granted A61PA61P5/06

Quick answer

US patent 10494632 (Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P5/06